Roche to acquire Poseida Therapeutics for $1.5bn
Roche has signed an agreement to acquire Poseida Therapeutics in a $1.5bn deal. The transaction includes Poseida’s clinical and pre-clinical CAR-T therapies and manufacturing capabilities. The acquisition will also integrate Poseida’s employees into Roche’ …